2005P-0411
  

  
 Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs 

  


  

  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC7538
  



  

  
Submitter : 
  

  
Mrs. Debra Brown-Cannon, RN, NP
  

  
Date & Time: 
  

  
03/06/2006 04:03:55
  



  

  
Organization : 
  

  
Mrs. Debra Brown-Cannon, RN, NP
  



  

  
Category : 
  

  
Health Professional
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 Dear Sirs,

As a woman who uses BHRT, as well as a nurse practitioner who prescribes these, I find it simply beyond belief that Wyeth Labs would have the audacity to ask that BHRT be restricted in ANY way. It is better in their opinion to use the urine of pregant horses, inhumanely handled at that, to dose human woman. How utterly ridiculous. Why should women be subjected to the increased risk of cancers because Wyeth is concerned that they will lose money to compounding pharmacies.  Compounding pharmacies are also essential in the hopsice industry to produce the pain relief compounds applied topically. Please do not bow to  the pressure of a huge pharmaceutical manufacturer. Compounding pharmacies MUST be allowed to continue to service the needs of millions of patients, male and female.  I would be willing to testify before any comittee. Thank you for your time.